Cargando…

Real-World Effectiveness of Dupilumab for Patients with Severe Asthma: A Retrospective Study

BACKGROUND: Treatment with dupilumab, an anti-interleukin (IL)-4 receptor α monoclonal antibody that blocks both the IL-4 and IL-13 pathways, has demonstrated efficacy for the treatment of severe asthma (SA) with type 2 inflammation. However, few studies have focused on the efficacy of this biologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Numata, Takanori, Araya, Jun, Miyagawa, Hanae, Okuda, Keitaro, Takekoshi, Daisuke, Hashimoto, Mitsuo, Minagawa, Shunsuke, Ishikawa, Takeo, Hara, Hiromichi, Kuwano, Kazuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982811/ https://www.ncbi.nlm.nih.gov/pubmed/35392537 http://dx.doi.org/10.2147/JAA.S357548

Ejemplares similares

Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study
por: Numata, Takanori, et al.
Publicado: (2021)

Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study
por: Numata, Takanori, et al.
Publicado: (2022)

Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
por: Numata, Takanori, et al.
Publicado: (2020)

Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP
por: Minagawa, Shunsuke, et al.
Publicado: (2022)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
por: Numata, Takanori, et al.
Publicado: (2019)

Possible relationship between esophageal dilatation and severity of M. abscessus pulmonary disease
por: Hara, Hiromichi, et al.
Publicado: (2021)

Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib
por: Takekoshi, Daisuke, et al.
Publicado: (2020)

Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis
por: Miyagawa, Hanae, et al.
Publicado: (2021)

Risk factors of postoperative pulmonary complications in patients with asthma and COPD
por: Numata, Takanori, et al.
Publicado: (2018)

Minoxidil-induced lung disease, masquerading as hypersensitivity pneumonitis
por: Takekosh, Daisuke, et al.
Publicado: (2023)

Interstitial Pneumonia in Psoriasis
por: Kawamoto, Hironori, et al.
Publicado: (2018)

Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma
por: Kawamoto, Hironori, et al.
Publicado: (2019)

Involvement of Parkin‐mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease‐related sarcopenia
por: Ito, Akihiko, et al.
Publicado: (2022)

Detection of pathogens by real-time PCR in adult patients with acute exacerbation of bronchial asthma
por: Yoshii, Yutaka, et al.
Publicado: (2017)

Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease
por: Fujii, Satoko, et al.
Publicado: (2012)

The usefulness of change in CT score for evaluating the activity of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD)
por: Shinfuku, Kyota, et al.
Publicado: (2023)

Mild Lung Tuberculosis in a Patient Suffering from Status Epilepticus Caused by the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)
por: Hashimoto, Mitsuo, et al.
Publicado: (2017)

A case of pulmonary lymphangioleiomyomatosis complicated with uterine and retroperitoneal tumors
por: Numata, Takanori, et al.
Publicado: (2015)

Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
por: Kurita, Yusuke, et al.
Publicado: (2017)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

Metformin attenuates lung fibrosis development via NOX4 suppression
por: Sato, Nahoko, et al.
Publicado: (2016)

Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalk
por: Kadota, Tsukasa, et al.
Publicado: (2021)

Chaperone‐mediated autophagy receptor modulates tumor growth and chemoresistance in non–small cell lung cancer
por: Ichikawa, Akihiro, et al.
Publicado: (2020)

Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
por: Gall, Rebecca, et al.
Publicado: (2023)

The Role of Dupilumab in Severe Asthma
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021)

PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis
por: Ito, Saburo, et al.
Publicado: (2015)

Correlation between Clinical Characteristics and Chest Computed Tomography Findings of Pulmonary Cryptococcosis
por: Yamakawa, Hideaki, et al.
Publicado: (2015)

Dupilumab: a novel treatment for asthma
por: Vatrella, Alessandro, et al.
Publicado: (2014)

Severe pediatric asthma therapy: Dupilumab
por: Ferrante, Giuliana, et al.
Publicado: (2022)

Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods
por: Shimizu, Kenichiro, et al.
Publicado: (2015)

Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis
por: Yoshida, Masahiro, et al.
Publicado: (2019)

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
por: van Dijk, Yoni E., et al.
Publicado: (2023)

Aspiration of Cerebrospinal Fluid Rhinorrhea as a Cause of Non-resolving Pneumonia
por: Takekoshi, Daisuke, et al.
Publicado: (2021)

Apoptosis inhibitor of macrophage (AIM) expression in alveolar macrophages in COPD
por: Kojima, Jun, et al.
Publicado: (2013)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022)

Successful treatment with dupilumab for mucus plugs in severe asthma
por: Anai, Moriyasu, et al.
Publicado: (2022)

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST
por: Maspero, Jorge F., et al.
Publicado: (2021)

Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program
por: Campisi, Raffaele, et al.
Publicado: (2021)

Long-lasting response to afatinib that persisted after treatment discontinuation in a case of EGFR-mutated lung adenocarcinoma
por: Yamanaka, Yumie, et al.
Publicado: (2019)

Simultaneous diagnosis of allergic bronchopulmonary aspergillosis and Mycobacterium avium complex lung disease
por: Takasaka, Naoki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kue03sftodme5smg96e6hek21v